Meriam Kabbaj
Hoofd Techniek/Wetenschap/O&O bij GENFIT
Actieve functies van Meriam Kabbaj
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| GENFIT | Hoofd Techniek/Wetenschap/O&O | 01-12-2022 | - |
Versantis AG
 Versantis AG BiotechnologyHealth Technology Versantis AG develops liver disease therapeutics and diagnostics. Its pipeline include VS-01, a drug to support liver, brain, and kidneys; VS-02 and VS-03 that are solutions for chronic liver diseases and treatment of drug intoxications; and other products for the treatment of metabolic academia and diagnosis of hyperammonemia. The company was founded by Vincent Forster and Meriam Kabbaj in 2015 and is headquartered in Zurich, Switzerland. | Directeur/Bestuurslid | 01-01-2015 | - |
| Operationeel Directeur | 01-01-2015 | - | |
| Oprichter | 01-01-2015 | - |
Loopbaan van Meriam Kabbaj
Opleiding van Meriam Kabbaj
| University of Montréal | Doctorate Degree |
Statistieken
Internationaal
| Canada | 2 |
| Zwitserland | 2 |
| Frankrijk | 2 |
Operationeel
| Doctorate Degree | 1 |
| Director/Board Member | 1 |
| Chief Operating Officer | 1 |
Sectoraal
| Health Technology | 3 |
| Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| GENFIT | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Versantis AG
Versantis AG BiotechnologyHealth Technology Versantis AG develops liver disease therapeutics and diagnostics. Its pipeline include VS-01, a drug to support liver, brain, and kidneys; VS-02 and VS-03 that are solutions for chronic liver diseases and treatment of drug intoxications; and other products for the treatment of metabolic academia and diagnosis of hyperammonemia. The company was founded by Vincent Forster and Meriam Kabbaj in 2015 and is headquartered in Zurich, Switzerland. | Health Technology |
- Beurs
- Insiders
- Meriam Kabbaj
- Ervaring
